Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/06/2007WO2007138103A1 Use of allopurinol for the treatment of palmar plantar erythrodysesthesia
12/06/2007WO2007138086A1 Long term 24 hour intestinal administration of levodopa/carbidopa
12/06/2007WO2007138081A1 PYRIMIDINO[1',6'-1,2]PYRIDO[3,4-b]INDOLE DERIVATIVES AND THEIR THERAPEUTIC USAGE
12/06/2007WO2007138072A2 Triazolopyrazine compounds useful for the treatment of degenerative & inflammatory diseases
12/06/2007WO2007138069A1 Lysine related derivatives as hiv aspartyl protease inhibitors
12/06/2007WO2007138050A1 Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
12/06/2007WO2007138048A1 Novel heterocyclic compounds
12/06/2007WO2007138047A2 Tri and tetra-oligo-saccharides suitable as agglutination agents for enteric pathogens
12/06/2007WO2007138041A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
12/06/2007WO2007138040A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
12/06/2007WO2007138039A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives and their medical use
12/06/2007WO2007138038A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
12/06/2007WO2007138037A1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
12/06/2007WO2007138033A1 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands
12/06/2007WO2007138022A2 Lipoic acid pellets
12/06/2007WO2007138017A1 1h-furo[3,2-c] pyrazole compounds useful as kinase inhibitors
12/06/2007WO2007137981A1 Inhibitors of tyrosine kinases
12/06/2007WO2007137980A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007WO2007137968A1 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
12/06/2007WO2007137955A1 Piperidinyl pyrimidine derivatives
12/06/2007WO2007137954A1 Aryl-4-ethynyl-isoxazole derivatives
12/06/2007WO2007137953A1 Benzazepine derivatives as monoamine reuptake inhibitors
12/06/2007WO2007137871A1 Combination of amino acid solution and a gelatin derivative for inhibiting renal uptake
12/06/2007WO2007137864A1 Use of inhibitors of pp2c for treating or preventing arteriosclerosis
12/06/2007WO2007137820A1 PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM
12/06/2007WO2007137819A1 4-AMINO-PYRIDO[3,2-e]PYRAZINES, THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE 10, AND PROCESSES FOR PREPARING THEM
12/06/2007WO2007137808A1 Compositions comprising oligosaccharides for treating prion disease
12/06/2007WO2007137801A1 Tetrahydropyrrolopyridine, tetrahydropyrazolopyridine, tetrahydro-imidazopyridine and tetrahydrotriazolopyridine derivatives and use thereof
12/06/2007WO2007137797A1 Gestagen combination and an insulin sensitizer for treating pcos
12/06/2007WO2007137793A1 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof
12/06/2007WO2007137792A1 Substituted heterocycles and use thereof
12/06/2007WO2007137790A1 Isoindolin-1-one-, isoindolin-3-one- and isoindolin-1,3-dione-derivatives and use thereof
12/06/2007WO2007137738A1 Spirocyclic nitriles as protease inhibitors
12/06/2007WO2007137674A1 Sulphated hyaluronic acid for treating degenerative osteoarthritis
12/06/2007WO2007137590A1 Sertindole for the preventive treatment of suicidal behaviour
12/06/2007WO2007137513A1 A TYPE OF NOVEL 2'-α-HYDROXYALKYL TAXEL COMPOUNDS AND THE PREPARATION METHODS THEREOF
12/06/2007WO2007137449A1 Compositions for treating and preventing hyperlipidemia
12/06/2007WO2007137417A1 Heterocyclic compounds as calcium channel blockers
12/06/2007WO2007137409A1 Treatment and prevention of cognitive decline
12/06/2007WO2007137400A1 Method and compound for the treatment of valvular stenosis
12/06/2007WO2007137380A1 Pharmaceutical product based on passiflora incarnata l., uses therefor and method to treat anxiety and insomnia
12/06/2007WO2007137342A1 Methods of modulating epithelial-mesenchymal transition and mesenchymal-epithelial transition in cells and agents useful for the same
12/06/2007WO2007137321A1 Improved tissue maintenance
12/06/2007WO2007127791A2 New pharmacological method for treatment of neuropathic pain
12/06/2007WO2007121917A3 Purine derivatives as adenosine receptor activator
12/06/2007WO2007120170A9 Compositions and methods for treating gram positive bacterial infection in a mammalian subject
12/06/2007WO2007118873A3 Polymorphs of atorvastatin sodium and magnesium salts
12/06/2007WO2007118711B1 17α-SUBSTITUTED 4-(3-OXOESTRA-4,9-DIEN-11β-YL)-BENZOIC ACID, ITS DERIVATIVES AND PROCESS FOR ITS PRODUCTION
12/06/2007WO2007118234A3 Modified -galactosyl ceramides for staining and stimulating natural killer t cells
12/06/2007WO2007118001A3 Azoxystrobin formulations
12/06/2007WO2007117760A3 Preparation of gemcitabine
12/06/2007WO2007117560A3 Piperidine and morpholine renin inhibitors
12/06/2007WO2007117398A3 Non-peptidic molecules for detecting and treating tumors
12/06/2007WO2007117272A9 Methods for treatment of hemorrhagic shock and related disorders
12/06/2007WO2007115997A3 Combination preparations from modafinil, ritalin and topiramat for use in cocaine dependency and/or for treating impulse control disorders
12/06/2007WO2007115381A3 Solid dispersion of poorly soluble drugs in graft copolymers
12/06/2007WO2007115315A3 Pyrrolo- and thiazolo-pyridine compounds as hif modulators
12/06/2007WO2007113680A3 Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use
12/06/2007WO2007112272A3 Formulations of low dose diclofenac and beta-cyclodextrin
12/06/2007WO2007110834A3 Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
12/06/2007WO2007110727A3 Amide stabilized hydroxyethylamines
12/06/2007WO2007110649A3 Process for the preparation of 2,6,9-trisubstituted purines
12/06/2007WO2007109456A3 Substituted biphenyl isoxazole sulfonamides as dual angiotensin endothelin receptor antagonists
12/06/2007WO2007109142A3 M3 muscarinic receptor antagonists for treating tumors
12/06/2007WO2007109102A3 Methods for interventions and testing for caloric restriction (cr) mimetics
12/06/2007WO2007109057A3 Solid dosage form containing a taste masked active agent
12/06/2007WO2007108001A3 Ligament remodeling
12/06/2007WO2007107869A3 Lipid derivatives
12/06/2007WO2007107828A3 Amine derivatives
12/06/2007WO2007107008A8 Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity
12/06/2007WO2007106675A3 Composition and method of retarding viral activity and reducing viral replication
12/06/2007WO2007106181A3 Glucagon receptor antagonists, preparation and therapeutic uses
12/06/2007WO2007105053A3 Tetralines antagonists of the h-3 receptor
12/06/2007WO2007103873A3 Pharmaceutical formulations of an anhydrous crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol
12/06/2007WO2007103869A3 Liquid and semi-solid pharmaceutical formulations and processes
12/06/2007WO2007103828A3 Fluorocytidine derivatives and cox-2 inhibitors for the treatment of cancer
12/06/2007WO2007103341A3 Composition for enhancing muscle mass development in animals
12/06/2007WO2007101252A3 Targeted delivery of pharmaceutical compounds
12/06/2007WO2007100374A9 Soft protease inhibitors and pro-soft forms thereof
12/06/2007WO2007099555A3 Pharmaceutical tablet compositions containing irbesartan
12/06/2007WO2007098467A3 Stable vitamin c compositions
12/06/2007WO2007098388A3 Oxa-steroids derivatives as selective progesterone receptor modulators
12/06/2007WO2007097889A3 Fluoroquinolone compositions
12/06/2007WO2007097770A8 Metoprolol succinate e.r. tablets and methods for their preparation
12/06/2007WO2007092338A3 Compositions comprising a bisphosphonate and an antifolate
12/06/2007WO2007092278A3 Withacnistin compounds for treatment of cancer
12/06/2007WO2007092153A3 Preparation of 7-alkenyl-3 quinolinecarbonitriles via a palladium mediated coupling reaction
12/06/2007WO2007089780A9 Bmx/etk tyrosine kinase gene therapy materials and methods
12/06/2007WO2007089685A3 Compositions and methods for inducing adipose tissue cell death
12/06/2007WO2007087231A3 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/06/2007WO2007087215A3 N-acetyl-cysteine and its derivatives as an antitussive
12/06/2007WO2007087150A3 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
12/06/2007WO2007084667A3 Fused heterobicyclic kinase inhibitors
12/06/2007WO2007084240A3 Anti-itch stick and method of use
12/06/2007WO2007081572A3 Inhibitors of checkpoint kinases
12/06/2007WO2007079916A3 Combination of triazine derivatives and hmg- coa reductase inhibitors for the treatment of diabetes
12/06/2007WO2007079470A3 Therapeutic amine-arylsulfonamide conjugate compounds
12/06/2007WO2007079186A3 1, 3-oxazolidin-2-one derivatives useful as cetp inhibitors
12/06/2007WO2007078679A3 Practical, cost-effective synthesis of ubiquinones
12/06/2007WO2007076360A8 (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions
1 ... 3469 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 3482 3483 3484 3485 3486 3487 3488 3489 ... 7860